The index rebounded today, and foreign investors continued to buy. The index continues to fall, there is an expectation of a rebound in the short term, today should be no problem, but tomorrow may be another adjustment, the near future is still a shock expectation.
The index is good, and the previous strong new crown testing and prefabricated dishes have fallen ahead! The market is still seesaw wheel, tomorrow may be the index down, these two sectors are stronger. As long as the general leader of Jiuan Medical has no problems, the direction of the epidemic will continue to strengthen.
Today's epidemic line is relatively strong is the concept of new crown drugs, after the suspension of the leading Yaben Chemical, the replenishment is all exploded! The new crown drug concept stocks in the Tongdaxin sector have all risen sharply! Essence Pharmaceutical is the leader, directly top a word, this is still a very good signal, today's direction is worth paying attention to. But now they are also up, it is not recommended to chase again. However, the branch of the new crown drug, barritinib, is not very good, the leader of the East Asian pharmaceutical industry has fried the board, this low-level ticket is fried, and other expectations are not high.
What is strong today is the concept of digital economy, but this concept, feel and technology are related, what 5G, big data, cloud computing, Internet of Things, etc., is not very good to focus. In this case, it is recommended to track the faucet, that is, the variety that has risen and fallen today, and then pay attention to the relay opportunity tomorrow. The ticket in the back row is also not recommended to chase high, and the rise is less, such as what tianyu information, Huayu software can be seen.
![The FTC lawsuit was approved by the court, and Facebook may face an antitrust split[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)